IDF general

IDF

IDF Guideline on self-monitoring of blood glucose in non-insulin treated type 2 diabetes

In October 2008, the International Diabetes Federation Clinical Guidelines Task Force, in conjunction with the SMBG International Working Group, convened a workshop in Amsterdam to address the issue of SMBG utilization in people with type 2 diabetes (T2M) that is not treated with insulin.

Global Guideline on pregnancy and diabetes

Pregnancy is associated with changes in insulin sensitivity which may lead to changes in plasma glucose levels. For women with known diabetes or for women who develop diabetes during the pregnancy, these changes can put outcomes at risk. This guideline deals with the means of identifying women for whom such problems are new, and helping them, as well as women already known to have diabetes, to achieve the desired outcome of a healthy mother and baby.

IDF Guideline on Oral Health for People with Diabetes

IDF newsletters

UN Summit on NCDs

National Diabetes Programmes

Diabetes and oral health - information for health professionals

Diabetes and oral health - information for the public

Individual country assessments

Among the aims of the International Diabetes Federation’s (IDF) Task Force is to help ensure access to insulin and other essential diabetes supplies to people with diabetes. In order to address situations where chronic problems exist with regards to the availability of and access to proper diabetes care it is important to better understand what the barriers to access are.

Sleep apnoea and type 2 diabetes

Recent research demonstrates the likelihood of a relationship between type 2 diabetes and obstructive sleep apnoea (OSA), the most common form of sleep disordered breathing. The IDF consensus statement on sleep apnoea and type 2 diabetes wants to raise awareness of the association between the two conditions, which have significant implications on public health and on the lives of individuals.
 
A few facts:

Pages